Canada· CA-DIN-02397137
STRIBILD
A emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat product containing elvitegravir + tenofovir disoproxil fumarate + emtricitabine + cobicistat, registered in Canada by GILEAD SCIENCES CANADA INC. The same ATC class is registered in 13 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR09 (emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat · ATC J05AR09
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- ELVITEGRAVIR + TENOFOVIR DISOPROXIL FUMARATE + EMTRICITABINE + COBICISTAT
- Manufacturer
- GILEAD SCIENCES CANADA INC
- Country
- Canada (CA)
- ATC code
- J05AR09
- ATC class
- Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandStribildParanova Oy
- CzechiaSTRIBILDGilead Sciences Ireland UC, Carrigtohill
- United KingdomStribild 150mg/150mg/200mg/245mg tabletsGilead Sciences Ltd
- IcelandStribildGilead Sciences Ireland UC*
- NorwayStribildGilead Sciences Ireland UC
- PolandStribildGilead Sciences Ireland UC
- SwedenStribild 150 mg/150 mg/200 mg/245 mg Filmdragerad tablettGilead Sciences Ireland UC
- SwitzerlandStribild, FilmtablettenGilead Sciences Switzerland Sàrl
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Stribild
- Liechtenstein · Stribild
- Norway · Stribild
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bd1ac161-874f-46b7-94a6-d0f005d4d1c7 GET /v1/drugs/bd1ac161-874f-46b7-94a6-d0f005d4d1c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02397137",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J05AR09",
"schedule": [
"Prescription"
],
"drug_code": "88208",
"strengths": [
"150 MG",
"300 MG",
"200 MG"
],
"ahfs_class": null,
"substances": [
"ELVITEGRAVIR",
"TENOFOVIR DISOPROXIL FUMARATE",
"EMTRICITABINE",
"COBICISTAT"
],
"product_categorization": null
}See everything about emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.